Number of shares and voting rights as at 31/12/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st December.
Half-year report on liquidity contract as at 31/12/2018
Under the liquidity contract agreed between the company and Kepler Cheuvreux, as at 31 December 2018.
Update on funding prospects
As stated in the previous press release, Europlasma Group and its management are actively pursuing the objective of achieving a capital increase allowing the entry of a reference shareholder and thus ensuring the continuity of its operations.
Read the press release (in French)
Number of shares and voting rights as at 30/11/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 30th November.
Participation in Pollutec exhibition
The Group attends the 28th international trade show for environmental equipment, technologies and services "Pollutec" from 27 to 30 November 2018 at Lyon Eurexpo.
CHO Power will exhibit in Energy Hall - H4 aisle G stand n°141
Europlasma and Inertam will exhibit in Waste Hall - H3 aisle B stand n°109
Suspension of the automatic issuance of the 4th warrant given access to convertible bonds
Europlasma has suspended, today, the 4th warrant given access to notes convertible into new shares (BEOCA).
Read the press release (in French)
ADEME published IGAR applicant sheet
ADEME has just published on its website the sheet relating to the IGAR program. This project aimed at significantly reducing CO2 emissions from steel industry in Europe. Europlasma is the main partner of this project, supported by ADEME and coordinated by Arcelor Mittal.
Read our press release of 26/02/2018
Number of shares and voting rights as at 31/10/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st October.
Half-year consolidated Resultats as at 30/06/2018
Europlasma announces its results for the half-year period ended 30/06/2018, which were subject to a limited review by the Board of Auditors and which were approved by the Board of Directors on October 30, 2018 .
Read the press release (in French)
Europlasma announces the reactivation of the financing agreement by issuance of convertible bonds
In the press release of September 3, 2018, Europlasma (the "Company") announced the suspension of the exercise of the third warrant given access to convertible bonds ("OCA") relating to the contract signed on July 17, 2018 (renewal of the contract concluded on February 9, 2018) with the Luxembourg fund European High Growth Opportunities Securitization Fund (the "Investor").
Read the press release (in French)